About OptoCeutics
OptoCeutics is a Healthcare company based in Kongens Lyngby (Denmark) founded in 2018 by Jes Broeng and Ngoc Mai Nguyen. Neurological diseases are treated and diagnosed using gamma stimulation therapy. OptoCeutics has raised $2.63 million across 7 funding rounds from investors including EIT Health, European Union and EIC Fund. OptoCeutics was last valued at $15.62 million in September 2020. Its chief executive, as recorded, is Ngoc Mai Nguyen. Its website optoceutics.com draws about 70 thousand monthly visits. OptoCeutics offers products and services including EVY and EVY App. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is Optoceutics ApS.
Company details
OptoCeutics was founded in 2018 in Kongens Lyngby, Denmark, as a provider of solutions for neurological disease treatment and diagnosis. Gamma stimulation therapy and digital biomarkers are utilized in its operations. New lighting technology is being developed, featuring non-perceptible gamma light that avoids vision issues or discomfort while data for diagnostics is continuously collected. The focus remains on healthcare innovations in the neurological sector.
- Headquarters Kongens Lyngby, Denmark
- Founders Jes Broeng, Ngoc Mai Nguyen
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website optoceutics.com
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Optoceutics Aps
- Total Equity Funding$2.63M (USD)
in 7 rounds
- Latest Funding Round$692.72K (USD), Grant
Nov 2020
- InvestorsEIT Health
& 2 more
Products & Services of OptoCeutics
OptoCeutics offers a comprehensive portfolio of products and services, including EVY and EVY App.
Provides 40 Hz light and sound for cognitive health enhancement.
App to monitor progress and usage of therapy device.
Apps and channels of OptoCeutics
its YouTube channel OptoCeutics has 203 subscribers and 30 videos.
Videos from OptoCeutics
The most watched videos on OptoCeutics's YouTube channel, OptoCeutics (203 subscribers). Click a video to play it here.
More on OptoCeutics.
Funding Insights of OptoCeutics
OptoCeutics has successfully raised a total of $2.63M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $692.72 thousand completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.63M
- Total Rounds 7
- Last Round Grant — $692,723
- First Round $661,361
(Mar 2019)
- Investors Count 3
All 7 funding rounds of OptoCeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2020 | $692,723 | Grant | – | – | |
| Sep 2020 | $1.81M | Seed | $15.62M | – | – |
| Jan 2020 | $159,284 | Seed | $9.77M | – | – |
| Sep 2019 | $54,684 | Grant | – | – | |
| Jun 2019 | Grant | – | – | ||
| May 2019 | $56,002 | Grant | – | – | |
| Mar 2019 | $661,361 | Seed | $••••• | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Sep 2020 | $15.62M | •••••••• |
| Jan 2020 | $9.77M | •••••••• |
Last known valuation $15.62M (Sep 2020). 3 investors in total: 3 institutional.
Investors in OptoCeutics
OptoCeutics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include EIT Health, European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Healthcare startups are accelerated and incubated through specialized programs. | 2015 | eithealth.eu | Munich, Germany | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for OptoCeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of OptoCeutics
2 people are tracked at OptoCeutics (2 in leadership).
| Name | Role | Group |
|---|---|---|
Jes Broeng | Co-Founder | Leadership |
Ngoc Mai Nguyen | Co-Founder & CEO | Leadership |
Complete people profiles for OptoCeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of OptoCeutics
4 dated milestones of OptoCeutics across 2 years, from founding to its latest funding, stage changes and deals.
- Founded OptoCeutics is founded.
- Funding First funding round of $661K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Grant, of $693K.
Web traffic of OptoCeutics
The website of OptoCeutics (optoceutics.com) receives about 70.2K visits a month.
- Monthly visits70.2K
▼ 8.2% vs previous month
Websites whose visitors overlap most with OptoCeutics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
gammalighttherapy.com | gammalighttherapy.com | 100% | #1,013,550 | – | |
cerebralpalsy.org | cerebralpalsy.org | 94% | #1,282,004 | – | |
alzinfo.org | alzinfo.org | 93% | #383,602 | – | |
theadultspeechtherapyworkbook.com | theadultspeechtherapyworkbook.com | 85% | #950,611 | – | |
| stroke.org.uk | 83% | 207.7K | #231,032 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for OptoCeutics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Optoceutics
Complete news archive for OptoCeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OptoCeutics
OptoCeutics was founded in 2018 and raised its 1st funding round 1 year after it was founded.
OptoCeutics is headquartered in Kongens Lyngby, Denmark. It is registered at Kongens Lyngby, Capital Region, Denmark.
Ngoc Mai Nguyen is the CEO of OptoCeutics, as recorded in our data. They have also founded this company.
OptoCeutics is a funded company, having raised a total of $2.63M across 7 funding rounds to date. The company's 1st funding round was a Seed of $661.36K, raised on Mar 2019.
OptoCeutics was founded in 2018 in Kongens Lyngby, Denmark, as a provider of solutions for neurological disease treatment and diagnosis. Gamma stimulation therapy and digital biomarkers are utilized in its operations. New lighting technology is being developed, featuring non-perceptible gamma light that avoids vision issues or discomfort while data for diagnostics is continuously collected. The focus remains on healthcare innovations in the neurological sector.
OptoCeutics offers EVY and EVY App.
OptoCeutics has 3 investors. Key investors include EIT Health, European Union, and EIC Fund.
The valuation of OptoCeutics is $15.62M as of Sep 2020.
OptoCeutics operates through Optoceutics Aps.